Clinical Trial Update: Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating pharmacogenetics and pharmacosurveillance of first-line diuretics in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Chlorthalidone (chlorthalidone)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

Sponsor: Federico II University | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED